Beyond Air, Inc. Operating Expenses
Beyond Air, Inc. (XAIR) reported Operating Expenses of $6.84 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-13
- Beyond Air, Inc. operating expenses for the quarter ending 2026-06-30 was $6.84M, a 12.04% decline year-over-year.
- Beyond Air, Inc. operating expenses for the quarter ending 2026-03-31 was $7.26M, a 1.71% increase year-over-year.
- Beyond Air, Inc. operating expenses for the quarter ending 2025-12-31 was $6.90M, a 35.77% decline year-over-year.
- Beyond Air, Inc. operating expenses for the quarter ending 2025-09-30 was $7.36M, a 37.33% decline year-over-year.
- Beyond Air, Inc. operating expenses for fiscal 2026 was $29.30M, a 31.67% decline from fiscal 2025.
- Beyond Air, Inc. operating expenses for fiscal 2025 was $42.87M, a 30.51% decline from fiscal 2024.
- Beyond Air, Inc. operating expenses for fiscal 2024 was $61.70M, a 19.80% increase from fiscal 2023.
- Beyond Air, Inc. operating expenses for fiscal 2023 was $51.50M, a 26.51% increase from fiscal 2022.
| Period end | Operating Expenses 3 month | Operating Expenses 3 month as first filed | Operating Expenses 6 month | Operating Expenses 6 month as first filed | Operating Expenses 8 month | Operating Expenses 9 month | Operating Expenses 9 month as first filed | Operating Expenses 12 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $6.84M 10-Q · filed 2026-08-13 | $14.10M derived: sum of 2 quarters · filed 2026-08-13 | $21.00M derived: sum of 3 quarters · filed 2026-08-13 | $28.36M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $7.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | $14.16M derived: sum of 2 quarters · filed 2026-06-26 | $21.52M derived: sum of 3 quarters · filed 2026-06-26 | $29.30M 10-K · filed 2026-06-26 | ||||
| 2025-12-31 | $6.90M 10-Q · filed 2026-02-13 | $14.26M derived: sum of 2 quarters · filed 2026-02-13 | $22.03M 10-Q · filed 2026-02-13 | $29.17M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-09-30 | $7.36M 10-Q · filed 2025-11-10 | $15.14M 10-Q · filed 2025-11-10 | $22.28M derived: sum of 3 quarters · filed 2026-08-13 | $33.02M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $7.77M 10-Q · filed 2026-08-13 | $14.91M derived: sum of 2 quarters · filed 2026-08-13 | $25.65M derived: sum of 3 quarters · filed 2026-08-13 | $37.40M derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $7.14M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-26 | $17.88M derived: sum of 2 quarters · filed 2026-06-26 | $29.63M derived: sum of 3 quarters · filed 2026-06-26 | $42.87M 10-K · filed 2026-06-26 | ||||
| 2024-12-31 | $10.74M 10-Q · filed 2026-02-13 | $22.48M derived: sum of 2 quarters · filed 2026-02-13 | $35.73M 10-Q · filed 2026-02-13 | $47.85M derived: sum of 4 quarters · filed 2026-02-13 | ||||
| 2024-09-30 | $11.75M 10-Q · filed 2025-11-10 | $25.00M 10-Q · filed 2025-11-10 | $37.12M derived: sum of 3 quarters · filed 2025-11-10 | $53.72M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $13.25M 10-Q · filed 2025-08-12 | $25.37M derived: sum of 2 quarters · filed 2025-08-12 | $41.98M derived: sum of 3 quarters · filed 2025-08-12 | $59.32M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | $12.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-20 | $28.73M derived: sum of 2 quarters · filed 2025-06-20 | $46.07M derived: sum of 3 quarters · filed 2025-06-20 | $61.70M 10-K · filed 2025-06-20 | ||||
| 2023-12-31 | $16.61M 10-Q · filed 2025-02-10 | $33.95M derived: sum of 2 quarters · filed 2025-02-10 | $49.58M 10-Q · filed 2025-02-10 | $63.26M derived: sum of 4 quarters · filed 2025-02-10 | ||||
| 2023-09-30 | $17.34M 10-Q · filed 2024-11-12 | $32.97M 10-Q · filed 2024-11-12 | $46.65M derived: sum of 3 quarters · filed 2024-11-12 | $60.59M derived: sum of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | $15.63M 10-Q · filed 2024-08-06 | $29.31M derived: sum of 2 quarters · filed 2024-08-06 | $43.25M derived: sum of 3 quarters · filed 2024-08-06 | $55.70M derived: sum of 4 quarters · filed 2024-08-06 | ||||
| 2023-03-31 | $13.68M derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-24 | $27.62M derived: sum of 2 quarters · filed 2024-06-24 | $40.06M derived: sum of 3 quarters · filed 2024-06-24 | $51.50M 10-K · filed 2024-06-24 | ||||
| 2022-12-31 | $13.94M 10-Q · filed 2024-02-12 | $26.38M derived: sum of 2 quarters · filed 2024-02-12 | $37.82M 10-Q · filed 2024-02-12 | $58.25M derived: sum of 4 quarters · filed 2024-02-12 | ||||
| 2022-09-30 | $12.44M 10-Q · filed 2023-11-13 | $23.88M 10-Q · filed 2023-11-13 | $44.31M derived: sum of 3 quarters · filed 2023-11-13 | $51.80M derived: sum of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | $11.44M 10-Q · filed 2023-08-10 | $31.87M derived: sum of 2 quarters · filed 2023-08-10 | $39.36M derived: sum of 3 quarters · filed 2023-08-10 | $45.56M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | $20.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-22 | $27.92M derived: sum of 2 quarters · filed 2023-06-22 | $34.12M derived: sum of 3 quarters · filed 2023-06-22 | $40.71M 10-K · filed 2023-06-22 | ||||
| 2021-12-31 | $7.49M 10-Q · filed 2023-02-10 | $13.69M derived: sum of 2 quarters · filed 2023-02-10 | $20.28M 10-Q · filed 2023-02-10 | |||||
| 2021-09-30 | $6.20M 10-Q · filed 2022-11-08 | $12.79M 10-Q · filed 2022-11-08 | ||||||
| 2021-06-30 | $6.59M 10-Q · filed 2022-08-11 | |||||||
| 2020-12-31 | $5.76M 10-Q · filed 2022-02-10 | $5.77M 10-Q · filed 2021-02-09 | $11.08M derived: sum of 2 quarters · filed 2022-02-10 | $17.91M 10-Q · filed 2022-02-10 | $17.91M 10-Q · filed 2021-02-09 | |||
| 2020-09-30 | $5.32M 10-Q · filed 2021-11-12 | $5.32M 10-Q · filed 2020-11-12 | $12.14M 10-Q · filed 2021-11-12 | $12.14M 10-Q · filed 2020-11-12 | ||||
| 2019-12-31 | $5.05M 10-Q · filed 2021-02-09 | $9.97M derived: sum of 2 quarters · filed 2021-02-09 | $14.47M 10-Q · filed 2021-02-09 | |||||
| 2019-09-30 | $4.91M 10-Q · filed 2020-11-12 | $9.42M 10-Q · filed 2020-11-12 | ||||||
| 2018-12-31 | $2.40M 10-Q · filed 2020-02-07 | $4.82M derived: sum of 2 quarters · filed 2020-02-07 | $6.57M 10-Q · filed 2020-02-07 | |||||
| 2018-09-30 | $2.41M 10-Q · filed 2019-11-06 | $4.17M 10-Q · filed 2019-11-06 | ||||||
| 2016-12-31 | $67.15K 10-K · filed 2017-03-31 | |||||||
| 2015-12-31 | $10.29K 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |